A discount prescription drug programme saved the elderly in Michigan, US, > $US16 million

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.313, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescription drug spending rises in elderly US insured

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Prescription drug costs for the elderly soar in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Drug discount cards for the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 357, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

A lack of prescription drug insurance is the most common barrier to prescription drug access for elderly individuals in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

The lowest-cost COX-2 inhibitor available through the US Medicare drug discount card programme is Merck's rofecoxib [Vioxx]

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 453, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite